NCT07046039

Brief Summary

The goal of this observational study is to learn about the prevalence and severity of untreated depression and anxiety among adults with skin diseases in Jeddah, Saudi Arabia. The main question it aims to answer is: Do patients with skin diseases experience significant levels of untreated depression and anxiety? Participants diagnosed with skin conditions such as acne, eczema, or psoriasis completed the PHQ-9 and GAD-7 questionnaires to assess their mental health symptoms. The study also explores whether factors like age or type of skin disease are associated with more severe psychological distress.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
215

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2024

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 23, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 1, 2025

Completed
Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

7 months

First QC Date

June 23, 2025

Last Update Submit

June 30, 2025

Conditions

Keywords

PsychodermatologyUntreated mental health

Outcome Measures

Primary Outcomes (2)

  • Prevalence of untreated anxiety

    The proportion of patients with dermatological conditions who score above the clinical threshold for anxiety on the Generalized Anxiety Disorder-7 (GAD-7) scale.

    1 day (Assessed at one point in time during the study.)

  • Prevalence of untreated depression

    The proportion of patients with dermatological conditions who score above the clinical threshold for depression on the Patient Health Questionnaire-9 (PHQ-9).

    1 day (Assessed at one point in time during the study.)

Secondary Outcomes (1)

  • Correlation between skin disease severity and psychological distress

    1 day (Assessed at one point in time during the study.)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult patients aged 18 to 65 years residing in Jeddah, Saudi Arabia, who have been diagnosed with one or more of the following dermatological conditions: acne vulgaris, atopic dermatitis (eczema), psoriasis, vitiligo, rosacea, hidradenitis suppurativa, or alopecia areata. Participants were recruited from dermatology outpatient clinics and through online social media platforms.

You may qualify if:

  • Adults aged 18 to 65 years
  • Residents of Jeddah, Saudi Arabia
  • Diagnosed with one or more of the following skin diseases: acne vulgaris, atopic dermatitis (eczema), psoriasis, vitiligo, rosacea, hidradenitis suppurativa, or alopecia areata
  • Able to complete the study questionnaire in Arabic or English

You may not qualify if:

  • Age below 18 or above 65 years
  • Absence of diagnosis for the specified skin diseases
  • Presence of chronic systemic illnesses such as diabetes, cardiovascular diseases, hypertension, or epilepsy
  • Inability to provide informed consent or complete the questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King Abdulaziz University - Faculty of Medicine

Jeddah, Saudi Arabia

Location

MeSH Terms

Conditions

Alopecia AreataAcne VulgarisPsoriasisDermatitis, AtopicEczemaRosaceaHidradenitis SuppurativaVitiligo

Condition Hierarchy (Ancestors)

AlopeciaHypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue DiseasesAcneiform EruptionsSebaceous Gland DiseasesSkin Diseases, PapulosquamousSkin Diseases, GeneticGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDermatitisSkin Diseases, EczematousHypersensitivity, ImmediateHypersensitivityImmune System DiseasesSkin Diseases, BacterialBacterial InfectionsBacterial Infections and MycosesInfectionsSkin Diseases, InfectiousSuppurationHidradenitisSweat Gland DiseasesHypopigmentationPigmentation Disorders

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical student Researcher

Study Record Dates

First Submitted

June 23, 2025

First Posted

July 1, 2025

Study Start

January 1, 2024

Primary Completion

July 29, 2024

Study Completion

July 29, 2024

Last Updated

July 1, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Although aggregate study results will be published, individual participant data (IPD) will not be shared because no identifiable data was collected, ensuring participant privacy and confidentiality.

Locations